FRESENIUS MEDICAL CARE AG vs NATIONAL HEALTHCARE CORP, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where FMS and NHC diverge most: on revenue growth, FMS reads +1.5% and NHC reads +11.0%; on ev/ebitda, FMS reads 3.7 and NHC reads 19.8. The rest of the comparable metrics sit closer together. What FMS's price implies is a bet that sits within the historical range (whole-company basis). What NHC's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | FMS | NHC |
|---|---|---|
| Price | $25.66 | $225.77 |
| Market cap | $15.0B | $3.6B |
| Sector | Medical Care | Medical Care |
| Stage | Mature | Mature |
| Implied growth (priced in) | — | +12.0% |
| P/E | 14.1 | 28.7 |
| P/B | 0.97 | 3.25 |
| P/S | 0.70 | 2.33 |
| EV/EBITDA | 3.7 | 19.8 |
| Revenue growth | +1.5% | +11.0% |
| Operating margin | 11.7% | 8.4% |
| Net margin | 6.1% | 8.1% |
| Return on equity | 8.3% | 11.3% |
| Return on assets | 3.8% | 8.1% |
| Return on invested capital | 10.1% | 9.5% |
| FCF yield | 19.4% | 4.7% |
| Dividend yield | 1.6% | 1.1% |
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 1.26 | 1.86 |
| Altman Z (solvency) | 1.81 | 7.03 |
| Piotroski F (quality) | 8 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.